Country Profile

Central African Republic

Central African Republic is a developing market for Indian pharmaceuticals — $5.66M in FY 2025–26. Vaccines accounts for 53% of shipments, with vaccines contributing $3.01M.

🇨🇫 $5.66M · 1.2× growth since FY2016 · 1.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$5.66M
Exports FY2025–26 DGCIS
1.2×
Growth FY2016→2026
1.9%
CAGR FY2016→2026
53%
Vaccines Share
3
Product Categories Supplied
Central African Republic is a developing market for Indian pharmaceuticals — $5.66M in FY 2025–26. Vaccines accounts for 53% of shipments, with vaccines contributing $3.01M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Vaccines $3.01M (53.3%) Medicines $2.61M (46.2%) Surgical & Hospital Supplies $32K (0.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Central African Republic in the RBI overseas direct investment dataset (2011–2026).